"The drug/device combination of ThermoDox and MR-HIFU has great synergy with the potential to provide an innovative, non-invasive therapy for patients with aggressive and life-threatening cancers," said Falko Busse, vice president and general manager, MR-HIFU, for Philips Healthcare. "We are excited about our continued collaboration with Celsion because the combination of our technologies could provide a more effective treatment for pancreatic cancer and bone metastases."
"Since the beginning of the collaboration in 2008, Philips and Celsion have made excellent progress to develop ThermoDox and MR-HIFU," added Michael H. Tardugno, president and chief executive officer for Celsion. "Initial feasibility work suggests that a combination of these technologies has the potential to significantly expand the market for ThermoDox; providing promise to thousands of patients with difficult to treat disease."
Ad Statistics
Times Displayed: 112999
Times Visited: 6736 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Philips and Celsion will both be in attendance at the upcoming International Symposium on Therapeutic Ultrasound held in Aix-en-Provence, France from September 23-26. The companies will be pleased to answer questions regarding the technologies at the Philips conference booth.
About Philips' MR Guided High Intensity Focused Ultrasound (MR-HIFU)
MR-guided High Intensity Focused Ultrasound, or MR-HIFU, is a new non-invasive technique with the potential to provide local tumor control and improve quality of life. The Philips MR-HIFU system combines the HIFU capability of non-invasively heating tissue deep inside the human body with the excellent soft tissue contrast, 3D imaging capabilities, and non-invasive temperature measurement techniques provided by MR to plan, guide and monitor the treatment.
The Philips MR-HIFU system offers a unique technique called Volumetric Heating. With this technique, essential for localized mild hyperthermia, the ultrasound focus is moved electronically over the volume to be heated and is monitored with real-time temperature sensitive MR images to create a uniform temperature distribution.
For the treatment of uterine fibroids, a prevalent condition in women of childbearing age, the Philips MR-HIFU system is currently being evaluated in a global multi-center clinical trial involving centers in North America, Europe and Asia.
About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified Health and Well-being company, focused on improving people's lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity". Headquartered in the Netherlands, Philips employs approximately 116,000 employees in more than 60 countries worldwide. With sales of EUR 26 billion in 2008, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in flat TV, male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.
